Project Grant R01DK140310
- This federal Project Grant award for $836,942 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research into the role of autophagy (self-digestion) in intestinal regeneration and stem cell activity. The research aims to investigate how autophagy contributes to injury resistance and the ability of certain intestinal cell types to re-acquire stem cell-like...
- This R03 project grant, awarded by the National Center for Advancing Translational Sciences (NCATS) under CFDA Program 93.350, aims to comprehensively identify metabolic enzymes that control the generation of TCF1+ progenitor CD8+ T cells, which are critical for durable anti-tumor immune responses. The $169,500 award, spanning from September 1, 2024 to August 31, 2026, will fund two key research objectives: Identifying metabolic enzymes whose loss alters T cell differentiation and the TCF1+...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is providing $1,060,675 to the University of Arizona to study the impact of the absent in melanoma 2 (AIM2) protein on intestinal stem cell differentiation during inflammation. The research aims to elucidate the molecular and cellular processes by which AIM2 regulates the development of...
- This $2,970,076 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to investigate the developmental programming of adult intestinal stem cells (ISCs) and how an obesogenic maternal environment during pre- and postnatal development can establish a maladaptive pre-pathological ground state in offspring. Using genetically engineered mouse and organoid models, the...
- This $715,501.00 Project Grant awarded on March 15, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at Columbia University's Health Sciences Division. The project aims to investigate the role of T helper cells and stem cells in colon homeostasis and tumor initiation. Key objectives include determining how T cell cytokines modulate colon stem cell...
- This federal Project Grant award of $153,768 from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) aims to elucidate the impact of peroxisome biogenesis on adaptive immune responses, particularly within the tumor microenvironment and anti-tumor immunity. The principal investigator at The Medical University of South Carolina will conduct research to delineate the mechanisms by which peroxisome capacity influences T cell exhaustion, lipid accumulation, and...
- This $812,621 Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to decipher the role of the cystic fibrosis transmembrane receptor (CFTR) in dietary fatty acid transport within the small intestine. The Principal Investigator is Alison B. Kohan, with Co-Principal Investigator CA Hodges. The project aims to use novel surgical...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), totals $129,619 and will fund research on the interactions between the gut microbiome, intestinal development, and metabolic health in the context of fetal growth restriction (FGR). The overarching goal is to investigate how impaired intestinal and gut microbial development in FGR increases the...
- This Project Grant award of $730,407, provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), supports research investigating how inhibition of the ULK1 protein kinase, which controls autophagy, can rewire the metabolism of lung tumor cells and tumor-infiltrating T cells. The key products and services to be delivered under this 5-year award include: Establishing the role of ULK1 inhibition in altering lung tumor cell metabolism in vivo using...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $421,600 to The Morgridge Institute for Research, Inc. to understand how metabolic conditions influence the behavior of human cells. The key products and services to be delivered under this 5-year award include: Elucidating genetic and environmental contributions to human cell fitness and growth, leveraging innovative tools such as a...
THE LYSOSOMAL FASTING RESPONSE IN INTESTINAL STEM CELLS AND CANCER - PROJECT SUMMARY FASTING IMPROVES ORGANISMAL HEALTH AND TISSUE HOMEOSTASIS IN PART BY ENHANCING STEM CELL ACTIVITY. IN ADDITION, STEM CELLS SERVE AS A CELL-OF-ORIGIN IN MULTIPLE CANCER TYPES; HOWEVER, HOW FASTING INFLUENCES TISSUE STEM CELLS REMAINS POORLY UNDERSTOOD. HERE WE PROPOSE TO DISSECT THE ROLE OF LYSOSOMES, A DYNAMIC SIGNALING ORGANELLE THAT ORCHESTRATES AND EXECUTES KEY ASPECTS OF THE INTESTINAL STEM CELL FASTING RESPONSE AND TUMORIGENESIS. LYSOSOMES CONTROL METABOLISM IN RESPONSE TO NUTRIENT AVAILABILITY, AND THEY CONTRIBUTE TO PROTEIN AND CELLULAR HOMEOSTASIS THROUGH CLEARANCE OF AGGREGATION IN PART THROUGH ITS FUNCTION CALLED AUTOPHAGY; A CRITICAL NEED IN THE FIELD IS TO UNCOVER THE RELEVANT AUTOPHAGIC CARGOS AND METABOLITES TO UNDERSTAND THEIR REGULATORY ROLES IN CELLULAR AND ORGANISMAL PHYSIOLOGY. USING THE MAMMALIAN INTESTINE AS A PARADIGM, WE AIM TO UNDERSTAND HOW LYSOSOMES MAINTAIN INTESTINAL STEM CELLS (ISCS) AND CONTRIBUTE TO TUMORIGENESIS, AS INSIGHTS INTO THIS BIOLOGICAL PROCESS CAN HELP DEVELOP THERAPIES BENEFITING HUMAN HEALTH. HERE WE FOCUS ON TWO LARGELY REDUNDANT TRANSCRIPTION FACTORS THAT ARE IMPORTANT FOR LYSOSOMAL BIOGENESIS, CALLED TFE3 AND TFEB: OUR CENTRAL HYPOTHESIS IS THAT TFE3 AND TFEB ORCHESTRATE THE LYSOSOME FASTING RESPONSE, AND THEY PLAY A CENTRAL ROLE IN COORDINATING INTER-ORGANELLAR COMMUNICATION TO MAINTAIN ISCS UNDER THE FASTED STATE BY ENGAGING THE PPAR DRIVEN, MITOCHONDRIAL FATTY ACID OXIDATION (FAO) PATHWAY. IN AIM 1, WE WILL CHARACTERIZE THE INTESTINE-SPECIFIC DELETION PHENOTYPES OF TFE3 TFEB DOUBLE MUTANTS IN BOTH FED AND FASTED CONDITIONS AND FURTHER TEST THE NECESSITY AND SUFFICIENCY OF THESE TRANSCRIPTION FACTORS IN DRIVING THE ISC FASTING RESPONSE. IN AIM 2, WE WILL INVESTIGATE THE MECHANISM BY WHICH LYSOSOMES SUPPORT ISCS BY EMPLOYING MULTIPLE MOLECULAR APPROACHES. FIRST, WE WILL DEFINE THE TRANSCRIPTION NETWORK ORCHESTRATED BY TFE3 AND TFEB. NEXT, WE WILL ISOLATE LYSOSOMES FROM AD LIBITUM OR FASTED ISCS TO DISCOVER METABOLOMIC AND PROTEIN CONTENTS. THE ADVANCE OF OUR APPROACH IS THE USE OF A RAPID LYSOSOMAL PURIFICATION METHOD (LYSOIP) THAT WE RECENTLY ADOPTED TO ENABLE CELL-TYPE SPECIFIC METABOLOMIC AND PROTEOMIC PROFILING FROM IN VIVO TISSUES IN A CELL- TYPE SPECIFIC MANNER. FURTHER, WE WILL INTERROGATE THE REGULATORY RELATIONSHIP BETWEEN TFE3, TFEB AND MITOCHONDRIAL FAO, A PATHWAY THAT WE PREVIOUSLY IDENTIFIED AS ESSENTIAL FOR ISCS MAINTENANCE IN FASTED CONDITIONS. IN AIM 3, WE WILL FOCUS ON UNDERSTANDING THE ROLE OF LYSOSOMES IN EARLY INTESTINAL TUMORIGENESIS. TO THIS END, THE WELL-ESTABLISHED APC MODEL OF INTESTINAL TUMORIGENESIS AND ORTHOTOPIC TRANSPLANTATION MODELS WILL BE USED TO ASK IF TFE3 AND TFEB CAN IMPACT INTESTINAL TUMOR INITIATION OR PROGRESSION. IN ADDITION, WE WILL PERFORM LYSOIP FROM PRIMARY TUMORS TO UNCOVER THEIR LYSOSOMAL CONTENTS. FINALLY, TO INVESTIGATE WHETHER THE LYSOSOMAL FASTING RESPONSE CAN BE SYNERGISTICALLY UTILIZED WITH CONVENTIONAL CHEMOTHERAPY, WE WILL PERFORM INTERMITTENT FASTING (IF) ON INTESTINAL ADENOMAS AND ASK WHETHER ESTABLISHED TUMORS SUBJECTED TO IF REGIMEN ARE MORE SENSITIZED TO AUTOPHAGY INHIBITION. BROADLY, THE PROPOSED RESEARCH WILL SHED INSIGHTS INTO STEM CELL FUNCTION, TUMORIGENESIS, AND MECHANISMS OF LYSOSOMAL REGULATION IN THE PHYSIOLOGICAL CONTEXT.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $591.9k | 6/19/25 | ||
| Not listed | $606.7k | 8/9/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
S6463S | Rockefeller University | Project Grant R01DK140310 | $177.0k | 9/26/24 |